The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
but if there is an area where there's a really clear difference it's down in the autoimmune category so if you look at any immune related events you can see that in the anti C4 plus gp1 100 group it's about 60% in both of those treatment groups versus 30%
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
and if you look at the grade three and four toxicities it's 10% in the uh antict 4 15% in the um antict 4 alone group and only 3% in the treatment
if you look at the grade three and four toxicities it's 10% in the uh antict 4 15% in the um antict 4 alone group and only 3% in the treatment
if you look at any immune related events you can see that in the anti C4 plus gp00 group it's about 60% in both of those treatment groups versus 30%